MAINBOARD IPO● UPCOMINGBSE & NSE

BioHeal Therapeutics India Ltd.

Symbol: BIOHEAL • Sector: Pharmaceuticals & Biotechnology

Indicative Grey Market Premium

+₹68 (18.89%)

As of 27 Sep 2026, 11:00 AM

Price Band₹340 - ₹360 (Indicative)

Issue Size₹720 Cr

Lot Size41 Shares

Min. Investment₹14,760

Overall SubscriptionUpcoming

Company Profile & Business Model

Research-driven oncology biosimilars and complex injectables exporter with active marketing authorizations across EU and Latin America.

Objects of the Public Issue

Clinical trials phase III for biosimilar portfolio (₹240 Cr)
Injectable sterile fill-finish line in Hyderabad (₹180 Cr)
Debt restructuring (₹100 Cr)

Financial Performance Summary

FY25 Revenue

₹610.5 Cr

Net Profit (PAT)

₹74.2 Cr

Earnings Per Share (EPS)

₹16.5

P/E Multiple

21.8x

Peer Industry P/E

32.5x

Return on Net Worth

20.6%

Official Regulatory FilingsSEBI ICDR Compliant

Prospectus & Statutory Documents

Official draft and final prospectuses filed with the Securities and Exchange Board of India (SEBI) and Registrar of Companies (ROC).

DRHP —•RHP —•Prospectus —

Loading official filing records...

Regulatory Disclaimer: Offer documents are hosted for research and information purposes only. Glocal Consultants advises prospective issuers on compliance and structuring. These documents do not constitute an offer to buy or sell securities.

Issue Lifecycle Timeline

Issue Opens: 2026-10-08

Issue Closes: 2026-10-12

Allotment Finalization: 2026-10-15

Official Listing Ceremony: 2026-10-20

Deal Intermediaries

Book Running Lead Manager:
Nomura / JM Financial

Registrar to Issue:
KFin Technologies Ltd

Advisory Role:
Capital Restructuring by Glocal Consultants

Planning an IPO?

Consult Glocal Consultants to assess eligibility, optimize pre-money valuation, and prepare DRHP filings.

Book a Consultation →